CASI PHARMACEUTICALS, INC. (CASIF) Capital expenditures 2020–2025
CASI PHARMACEUTICALS, INC. (CASIF) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$16,000FY2025 · since FY2020: $1.5M → $16,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $16,000 | -92.8% |
| FY2024 | $223,000 | +9.3% |
| FY2023 | $204,000 | -96.4% |
| FY2022 | $5.6M | -37.3% |
| FY2021 | $8.9M | +496.7% |
| FY2020 | $1.5M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice